bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.02.24.528183

A validation approach for computational models of TMSinduced brain currents using motor evoked potentials

Abstract

The adoption of transcranial magnetic stimulation (TMS) has steadily increased in research as a tool capable to safely and non-invasively stimulate both the central and peripheral nervous systems. Initial clinical applications were limited to diagnostic use of TMS and readout signals such as electromyograms (EMG). Subsequently, repetitive TMS (rTMS) was appreciated for its therapeutics benefits as well. However, even after a decade of use of rTMS as an alternative treatment of major depression disorder in psychiatry, the mechanism of action is still not well understood. Computer models predicting the induced electric field distribution in the brain have been suggested before in the hope to resolve at least some of the uncertainty and resulting variable treatment response associated with the clinical use of TMS. We constructed a finite element model (FEM) of the head using individual volumetric tissue meshes obtained from an MRI scan and a detailed model of a TMS coil that together can predict the current induced in the head of a patient at any given location with any given coil position and orientation. We further designed several potential metrics of how a TMS induced current induced neuronal activation in the motor cortex, and added this to the model. We validated this model with motor evoked potentials (MEPs), EMG responses of the hand muscles after TMS on the motor cortex, in an experiment on 9 healthy subjects. We adopted a tailored MEP mapping protocol for model validation, which unlike traditional grid mappings, varies the TMS machine output intensity between stimulation locations. We further varied coil orientation on each point stimulated to allow exploration of the angular dependency of the model MEPs. Taken together, this approach covers a wide domain and scope of the modeled and measured responses, which are optimally suited for model validation. For each subject the motor hotspot was carefully identified using individual cortical anatomy and BOLD fMRI measurements. Modeled activation in the motor cortex did not show a good correlation to the observed magnitude of the observed MEPs, for none of the neuronal activation metrics adopted. For an activation metric that was asymmetric, taking into account induced current direction with respect to the motor cortex sulcal wall, was marginally better than other metrics. Generally all activation metrics based on induced currents performed better than a control metric agnostic of induced electric field magnitude. Our results suggest that one should take into account components of the injected currents and their relationship to the morphology of the underlying motor cortex, but the coarse metrics we used to model the relationship between induced current and neuronal activation probably did not do justice to the complex neuronal circuitry of the cortical sheet. Furthermore, it seemed MEP magnitudes in our experiment are too variable over subsequent stimulations, which could be mitigated by more repetitions per stimulation location and orientation. Further efforts to construct validated models predicting TMS effects in individual patients brains should incorporate microcircuits interactions in the cortical sheet, in addition to induced electrical field models, and take into account inherent trial to trial variability of MEPs.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Petrov, P. I., Vink, J., Mandija, S., van den Berg, N. A. T., Dijkhuizen, R. M., Neggers, S. F. W.. 2023-02-24. A validation approach for computational models of TMSinduced brain currents using motor evoked potentials. https://doi.org/10.1101/2023.02.24.528183

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗